Prime Medicine, The Next Gen Gene Editing Startup Raises $315 Million

Prime Medicine, a biotech startup working on a new approach to gene editing, has officially pulled back the curtain on the progress it has made since beginning operations last summer. The company “launched” on Tuesday, revealing it’s raised $315 million in short order from a large group of well-known biotech backers, including Arch Venture Partners,…

Editing A Person’s Brain Cells To Curb The Opioid Epidemic

Even as the COVID-19 pandemic cripples the economy and kills hundreds of people each day, there is another epidemic that continues to kill tens of thousands of people each year through opioid drug overdose. Opioid analgesic drugs, like morphine and oxycodone, are the classic double-edged swords. They are the very best drugs to stop severe…